title: Patient with colorectal cancer with heterogeneous KRAS molecular status responding to cetuximab-based chemotherapy.
authors.affiliation: San Camillo-Forlanini Hospital, Rome, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Mancuso
authors.forename: Rossella
authors.initials: R
authors.lastname: Sollami
authors.forename: Federica
authors.initials: F
authors.lastname: Recine
authors.forename: Linda
authors.initials: L
authors.lastname: Cerbone
authors.forename: Maria Cristina
authors.initials: MC
authors.lastname: Macciomei
authors.forename: Alvaro
authors.initials: A
authors.lastname: Leone
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics / Q000628:therapy*; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000235:genetics / Q000628:therapy*; D006801:Humans; D008297:Male; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins / Q000235:genetics*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; C117307:KRAS protein, human; D011518:Proto-Oncogene Proteins; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins; D000068818:Cetuximab